Advertisement

Cholesterol Transport and Production in Alzheimer’s Disease

  • Judes Poirier
  • Louise Lamarre-Théroux
  • Doris Dea
  • Nicole Aumont
  • Jean Francois Blain
Conference paper
Part of the Advances in Behavioral Biology book series (ABBI, volume 57)

Keywords

Cholesterol Synthesis Cholesterol Homeostasis HMGR Activity Dendritic Spine Morphology ApoE mRNA 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Poirier J (1994) Apolipoprotein E in animal models of CNS injury and in Alzheimer's disease. TINS 17:525–530PubMedGoogle Scholar
  2. 2.
    Elshourbagy NA, Liao WS, Mahley RW, Taylor JM (1985) Apolipoprotein E mRNA is abundant in the brain and adrenals, as well as in the liver, and is present in other peripheral tissues of rats and marmosets. Proc Natl Acad Sci U S A 82:203–207PubMedCrossRefGoogle Scholar
  3. 3.
    Poirier J (2003) Apolipoprotein E and cholesterol metabolism in the pathogenesis and treatment of Alzheimer's disease. Trends Mol Med 9:94–101PubMedCrossRefGoogle Scholar
  4. 4.
    Castillo M, Zafra MF, Garcia-Peregrin E (1988) Inhibition of brain and liver 3-hydroxy-3-methylglutaryl-CoA reductase and mevalonate-5-pyrophosphate decarboxylase in experimental hyperphenylalaninemia. Neurochem Res 13:551–555PubMedCrossRefGoogle Scholar
  5. 5.
    Shefer S, Tint GS, Jean-Guillaume D, et al (2000) Is there a relationship between 3-hydroxy-3-methylglutaryl coenzyme A reductase activity and forebrain pathology in the PKU mouse? J Neurosci Res 61:549–563PubMedCrossRefGoogle Scholar
  6. 6.
    Toews AD, Roe EB, Goodrum JF, et al (1997) Tellurium causes dose-dependent coordinate down-regulation of myelin gene expression. Mol Brain Res 49:113–119PubMedCrossRefGoogle Scholar
  7. 7.
    LaDu MJ, Gilligan SM, Lukens JR, et al (1998) Nascent astrocyte particles differ from lipoproteins in CSF. J Neurochem 70:2070–2081PubMedCrossRefGoogle Scholar
  8. 8.
    Utermann G, Langenbeck U, Beisiegel U, Weber W (1980) Genetics of the apolipoprotein E system in man. Am J Hum Genet 32:339–347PubMedGoogle Scholar
  9. 9.
    Davignon J, Gregg RE, Sing CF (1988) Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis 8:1–21PubMedGoogle Scholar
  10. 10.
    Arendt T, Schindler C, Bruckner MK, et al (1997) Plastic neuronal remodeling is impaired in patients with Alzheimer's disease carrying apolipoprotein epsilon 4 allele. J Neurosci 17:516–529PubMedGoogle Scholar
  11. 11.
    Ji Y, Gong Y, Gan W, et al (2003a) Apolipoprotein E isoform-specific regulation of dendritic spine morphology in apolipoprotein E transgenic mice and Alzheimer's disease patients. Neuroscience 122:305–315CrossRefGoogle Scholar
  12. 12.
    Ji Y, Gong Y, Gan W, et al (2003b) Apolipoprotein E isoform-specific regulation of dendritic spine morphology in apolipoprotein E transgenic mice and Alzheimer's disease patients. Neuroscience 122:305–315CrossRefGoogle Scholar
  13. 13.
    Poirier J, Delisle MC, Quirion R, et al (1995) Apolipoprotein E4 allele as a predictor of cholinergic deficits and treatment outcome in Alzheimer disease. Proc Natl Acad Sci USA 92:12260–12264PubMedCrossRefGoogle Scholar
  14. 14.
    Poirier J, Davignon J, Bouthillier D, et al (1993b) Apolipoprotein E polymorphism and Alzheimer's disease. Lancet 342:697–699CrossRefGoogle Scholar
  15. 15.
    Strittmatter WJ, Saunders AM, Schmechel D, et al (1993) Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci U S A 90:1977–1981PubMedCrossRefGoogle Scholar
  16. 16.
    Brown MS, Goldstein JL, Siperstein MD (1973) Regulation of cholesterol synthesis in normal and malignant tissue. Fed Proc 32:2168–2173PubMedGoogle Scholar
  17. 17.
    Boyles JK, Zoellner CD, Anderson LJ, et al (1989) A role for apolipoprotein E, apolipoprotein A-I, and low density lipoprotein receptors in cholesterol transport during regeneration and remyelination of the rat sciatic nerve. J Clin Invest 83:1015–1031PubMedCrossRefGoogle Scholar
  18. 18.
    Poirier J, Hess M, May PC, Finch CE (1991) Astrocytic apolipoprotein E messenger-RNA and GFAP messenger-RRNA in hippocampus after entorhinal cortex lesioning. Mol Brain Res 11:97–106PubMedCrossRefGoogle Scholar
  19. 19.
    Poirier J, Baccichet A, Dea D, Gauthier S (1993a) Cholesterol synthesis and lipoprotein reuptake during synaptic remodelling in hippocampus in adult rats. Neuroscience 55:81–90CrossRefGoogle Scholar
  20. 20.
    Aleong R, Aumont N, Dea D, Poirier J (2003) Non-steroidal anti-inflammatory drugs mediate increased in vitro glial expression of apolipoprotein E protein. Eur J Neurosci 18:1428–1438PubMedCrossRefGoogle Scholar
  21. 21.
    Jick H, Zornberg GL, Jick SS, et al (2000) Statins and the risk of dementia. Lancet 356:1627–1631PubMedCrossRefGoogle Scholar
  22. 22.
    Rockwood K, Kirkland S, Hogan SB, et al (2002) Use of lipid-lowering agents, indication bias, and the risk of dementia in community-dwelling elderly people. Arch Neurol 59:223–227PubMedCrossRefGoogle Scholar
  23. 23.
    Wolozin B, Kellman W, Ruosseau P, et al (2000) Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors. Arch Neurol 57:1439–1443PubMedCrossRefGoogle Scholar
  24. 24.
    Wagstaff LR, Mitton MW, Arvik BM,. Doraiswamy PM (2003) Statin-associated memory loss: analysis of 60 case reports and review of the literature. Pharmacotherapy 23:871–880PubMedCrossRefGoogle Scholar
  25. 25.
    Zamrini E, McGwin G, Roseman JM (2004) Association between statin use and Alzheimer's disease. Neuroepidemiology 23:94–98.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2008

Authors and Affiliations

  • Judes Poirier
    • 1
  • Louise Lamarre-Théroux
  • Doris Dea
  • Nicole Aumont
  • Jean Francois Blain
  1. 1.McGill Centre for Studies in Aging, McGill UniversityMontrealCanada

Personalised recommendations